The Signaling Pathways and Targets of Natural Compounds from Traditional Chinese Medicine in Treating Ischemic Stroke

The Signaling Pathways and Targets of Natural Compounds from Traditional Chinese Medicine in Treating Ischemic Stroke

Ischemic stroke (IS) is a common neurological disorder associated with high disability rates and mortality rates. At present, recombinant tissue plasminogen activator (r-tPA) is the only US(FDA)-approved drug for IS. However, due to the narrow therapeutic window and risk of intracerebral hemorrhage,...

Full description

Bibliographic Details
Main Authors: Xing-Hua Li, Feng-Ting Yin, Xiao-Hang Zhou, Ai-Hua Zhang, Hui Sun, Guang-Li Yan, Xi-Jun Wang
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Molecules
Subjects:
ischemic stroke
natural compounds
traditional Chinese medicine
signaling pathways
targets
Online Access:https://www.mdpi.com/1420-3049/27/10/3099

Internet

https://www.mdpi.com/1420-3049/27/10/3099

Similar Items